Alnylam Pharmaceuticals, Inc. (ALNY)
235.26
+3.43
(+1.48%)
USD |
NASDAQ |
Oct 19, 13:19
Alnylam Pharmaceuticals Cash from Operations (Annual) : 524.08M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 524.08M |
| December 31, 2024 | -8.312M |
| December 31, 2023 | 104.16M |
| December 31, 2022 | -541.27M |
| December 31, 2021 | -641.69M |
| December 31, 2020 | -614.96M |
| December 31, 2019 | -278.43M |
| December 31, 2018 | -562.62M |
| December 31, 2017 | -382.79M |
| December 31, 2016 | -307.70M |
| December 31, 2015 | -189.14M |
| December 31, 2014 | -165.64M |
| Date | Value |
|---|---|
| December 31, 2013 | -68.66M |
| December 31, 2012 | -115.61M |
| December 31, 2011 | -87.07M |
| December 31, 2010 | -84.34M |
| December 31, 2009 | -72.14M |
| December 31, 2008 | 65.49M |
| December 31, 2007 | 196.52M |
| December 31, 2006 | -24.63M |
| December 31, 2005 | -16.48M |
| December 31, 2004 | -19.57M |
| December 31, 2003 | -12.83M |
| December 31, 2002 | -1.278M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Ionis Pharmaceuticals, Inc. | -268.58M |
| BridgeBio Pharma, Inc. | -445.91M |
| Regeneron Pharmaceuticals, Inc. | 4.979B |
| Vertex Pharmaceuticals, Inc. | 3.631B |
| Pfizer Inc. | 11.70B |